The paper, entitled “Excellent Outcomes in a Geriatric Patient with Multiple Brain Metastases Undergoing Surgical Resection with Cesium-131 Implantation and Stereotactic Radiosurgery,” represents the most recent publication from the Departments of Neurological Surgery and Radiation Oncology at NewYork-Presbyterian Hospital and Weill Cornell Medical Center.

Under the Supply Agreement, IsoRay will exclusively manufacture and supply a brachytherapy product, known as GammaTile™, that incorporates its proprietary Cesium-131 seeds within customizable carriers, configured as squares or rectangles, for the treatment of brain tumors.